Contraceptive Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Distribution Channel, By End User, By Region & Competition, 2021-2031F

Description

The Global Contraceptive Devices Market will grow from USD 11.54 Billion in 2025 to USD 16.53 Billion by 2031 at a 6.17% CAGR. Contraceptive devices encompass a spectrum of medical implants, physical barriers, and intrauterine systems designed to prevent pregnancy by interfering with the reproductive process.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 11.54 Billion
Market Size 2031	USD 16.53 Billion
CAGR 2026-2031	6.17%
Fastest Growing Segment	Diaphragms
Largest Market	North America

Key Market Drivers

The rising prevalence of sexually transmitted infections (STIs) acts as a critical catalyst for the Global Contraceptive Devices Market, necessitating the adoption of barrier methods that offer dual protection against both unintended conception and disease transmission. This surge in infection rates compels public health bodies to aggressively promote condom usage and other physical barriers, thereby sustaining high-volume sales distinct from hormonal implants or intrauterine systems. The urgency of this driver is underscored by recent epidemiological data indicating a failure to curb specific transmission rates globally.

Key Market Challenges

The high costs associated with long-acting reversible contraceptives (LARCs) and the limited healthcare infrastructure in developing regions constitute a severe restraint on the global contraceptive devices market. Unlike short-term methods, implants and intrauterine systems require significant upfront expenditure and trained medical personnel for insertion, creating a heavy dependency on external funding and robust clinical networks. When supply chains fracture or donor allocations stagnate, these higher-value devices become inaccessible to the populations that need them most. This financial and logistical disconnect prevents the conversion of potential demand into actual market adoption, effectively capping market volume and revenue potential in high-demand regions.

Key Market Trends

The emergence of reversible male contraceptive technologies is fundamentally altering the sector by introducing viable alternatives to female-centric methods. This trend centers on the development of non-hormonal, vas-occlusive hydrogels that provide long-term efficacy comparable to vasectomies while ensuring reversibility, thereby addressing the significant unmet demand for shared reproductive responsibility. These innovations are progressing rapidly through clinical validation, proving that reliable male-focused devices can effectively disrupt the traditional market reliance on condoms and permanent sterilization.

Key Market Players

Cooper Surgical, Inc.
Pfizer, Inc
Merck & Co Inc
AbbVie, Inc
Teva Pharmaceutical Industries Limited
Ansell Ltd
Bayer AG
Mayer Laboratories Inc
Church & Dwight Co Inc
Reckitt Benckiser Group plc

Report Scope:

In this report, the Global Contraceptive Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contraceptive Devices Market, By Product Type:

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUDs)
and Others

Contraceptive Devices Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
and Others

Contraceptive Devices Market, By End User:

Male
and Female

Contraceptive Devices Market, By Region:

North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Contraceptive Devices Market.

Available Customizations:

Global Contraceptive Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Contraceptive Devices Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Devices (IUDs), and Others)
- 5.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
- 5.2.3. By End User (Male, and Female)
- 5.2.4. By Region
- 5.2.5. By Company (2025)
5.3. Market Map

6. North America Contraceptive Devices Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product Type
- 6.2.2. By Distribution Channel
- 6.2.3. By End User
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Contraceptive Devices Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product Type
    - 6.3.1.2.2. By Distribution Channel
    - 6.3.1.2.3. By End User
- 6.3.2. Canada Contraceptive Devices Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product Type
    - 6.3.2.2.2. By Distribution Channel
    - 6.3.2.2.3. By End User
- 6.3.3. Mexico Contraceptive Devices Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product Type
    - 6.3.3.2.2. By Distribution Channel
    - 6.3.3.2.3. By End User

7. Europe Contraceptive Devices Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product Type
- 7.2.2. By Distribution Channel
- 7.2.3. By End User
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Contraceptive Devices Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product Type
    - 7.3.1.2.2. By Distribution Channel
    - 7.3.1.2.3. By End User
- 7.3.2. France Contraceptive Devices Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product Type
    - 7.3.2.2.2. By Distribution Channel
    - 7.3.2.2.3. By End User
- 7.3.3. United Kingdom Contraceptive Devices Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product Type
    - 7.3.3.2.2. By Distribution Channel
    - 7.3.3.2.3. By End User
- 7.3.4. Italy Contraceptive Devices Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product Type
    - 7.3.4.2.2. By Distribution Channel
    - 7.3.4.2.3. By End User
- 7.3.5. Spain Contraceptive Devices Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product Type
    - 7.3.5.2.2. By Distribution Channel
    - 7.3.5.2.3. By End User

8. Asia Pacific Contraceptive Devices Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product Type
- 8.2.2. By Distribution Channel
- 8.2.3. By End User
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Contraceptive Devices Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product Type
    - 8.3.1.2.2. By Distribution Channel
    - 8.3.1.2.3. By End User
- 8.3.2. India Contraceptive Devices Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product Type
    - 8.3.2.2.2. By Distribution Channel
    - 8.3.2.2.3. By End User
- 8.3.3. Japan Contraceptive Devices Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product Type
    - 8.3.3.2.2. By Distribution Channel
    - 8.3.3.2.3. By End User
- 8.3.4. South Korea Contraceptive Devices Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product Type
    - 8.3.4.2.2. By Distribution Channel
    - 8.3.4.2.3. By End User
- 8.3.5. Australia Contraceptive Devices Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product Type
    - 8.3.5.2.2. By Distribution Channel
    - 8.3.5.2.3. By End User

9. Middle East & Africa Contraceptive Devices Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product Type
- 9.2.2. By Distribution Channel
- 9.2.3. By End User
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Contraceptive Devices Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product Type
    - 9.3.1.2.2. By Distribution Channel
    - 9.3.1.2.3. By End User
- 9.3.2. UAE Contraceptive Devices Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product Type
    - 9.3.2.2.2. By Distribution Channel
    - 9.3.2.2.3. By End User
- 9.3.3. South Africa Contraceptive Devices Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product Type
    - 9.3.3.2.2. By Distribution Channel
    - 9.3.3.2.3. By End User

10. South America Contraceptive Devices Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product Type
- 10.2.2. By Distribution Channel
- 10.2.3. By End User
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Contraceptive Devices Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product Type
    - 10.3.1.2.2. By Distribution Channel
    - 10.3.1.2.3. By End User
- 10.3.2. Colombia Contraceptive Devices Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product Type
    - 10.3.2.2.2. By Distribution Channel
    - 10.3.2.2.3. By End User
- 10.3.3. Argentina Contraceptive Devices Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product Type
    - 10.3.3.2.2. By Distribution Channel
    - 10.3.3.2.3. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Contraceptive Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Cooper Surgical, Inc.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Pfizer, Inc
15.3. Merck & Co Inc
15.4. AbbVie, Inc
15.5. Teva Pharmaceutical Industries Limited
15.6. Ansell Ltd
15.7. Bayer AG
15.8. Mayer Laboratories Inc
15.9. Church & Dwight Co Inc
15.10. Reckitt Benckiser Group plc